Related Experiment Video

Updated: Jul 16, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Bacterial pneumonia vaccines and childhood pneumonia: are we winning, refining, or redefining?

Stephen K Obaro1, Shabir A Madhi

  • 1Children's Hospital of Pittsburgh, Pittsburgh, PA 15213-2583, USA. Stephen.Obaro@chp.edu

The Lancet. Infectious Diseases
|February 28, 2006
PubMed

Insights

Accurately diagnosing bacterial pneumonia in children is difficult due to non-specific tests and rising antibiotic resistance. Improved diagnostic methods are crucial for effective surveillance and vaccine strategy evaluation.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Bacterial pneumonia significantly impacts global child health, yet pathogen-specific burden is hard to determine.
  • Current diagnostic methods like blood culture and radiography lack specificity and sensitivity for bacterial pneumonia.
  • Accurate surveillance is hindered by antibiotic resistance, novel pathogens, and vaccine-induced disease shifts.

Purpose of the Study:

  • To provide an overview of the diagnostic challenges in childhood bacterial pneumonia.
  • To emphasize the need for improved diagnostic approaches for epidemiological surveillance.
  • To assess the impact of diagnostic limitations on evaluating immunization strategies.

Main Methods:

  • Review of current diagnostic challenges in bacterial pneumonia surveillance.
  • Analysis of limitations in existing diagnostic tools (blood culture, radiography).
  • Discussion of factors affecting vaccine efficacy studies in pneumonia.

Main Results:

  • Existing diagnostic methods are insufficient for accurate pathogen identification and burden assessment.
  • Vaccine efficacy studies may underestimate the true burden of bacterial pneumonia.
  • Challenges include low sensitivity of blood cultures and non-specific radiological findings.

Conclusions:

  • Refining diagnostic approaches is essential for accurate childhood pneumonia surveillance.
  • Improved diagnostics are necessary to effectively monitor the success of immunization programs.
  • Addressing diagnostic limitations is critical for public health strategies against bacterial pneumonia.

More Related Videos

Experimental Model to Evaluate Resolution of Pneumonia09:49

Experimental Model to Evaluate Resolution of Pneumonia

Published on: February 17, 2023

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...